Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy

Current Eye Research

Volumn 39, Issue 5, 2014, Pages 532-536

  Du, Yi ^a   Ye, Huijing ^a   Li, Kaijun ^b   Xiao, Xin ^c   Chen, Rongxin ^a   He, Jian Feng ^b   Yang, Huasheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

Author keywords

Dysthyroid optic neuropathy; Graves' ophthalmopathy; Quality of life; Thyroid associated ophthalmopathy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COLOR VISION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DYSTHYROID OPTIC NEUROPATHY; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; MALE; MENTAL HEALTH; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OPTIC NERVE DISEASE; PERIPHERAL VISION; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL STATUS; VISION; VISUAL ACUITY; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; VISION DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; VISION DISORDERS; VISUAL ACUITY; YOUNG ADULT;

EID: 84898489154     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.848901     Document Type: Article

References (19)

1. McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, Dickinson AJ, et al. Clinical features of dysthyroid optic neuropathy: A European Group on Graves' Orbitopathy (EUGOGO) survey. Br J Ophthalmol 2007;91:455-458
2. Choi YJ, Lim HT, Lee SJ, Lee SY, Yoon JS. Assessing Graves' ophthalmopathy-specific quality of life in Korean patients. Eye 2012;26:544-551
3. Wiersinga WM, Prummel MF, Mourits MP, Koornneef L, Buller HR. Classification of the eye changes of Graves' disease. Thyroid 1991;1:357-360
4. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: The GO-QOL. Br J Ophthalmol 1998;82:773-779
5. Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S. Visionrelated quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2003;121: 1297-1302
6. Chakravarthy U, Stevenson M. Self-reported visual functioning and quality of life in age-related macular degeneration. Curr Opin Ophthalmol 2005;16:179-183
7. Cole SR, Beck RW, Moke PS, Gal RL, Long DT. The National Eye Institute Visual Function Questionnaire: Experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 2000;41: 1017-1021
8. Wren PA, Musch DC, Janz NK, Niziol LM, Guire KE, Gillespie BW, et al. Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-Angle glaucoma. J Glaucoma 2009;18:403-411
9. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-1058
10. Chan CW, Wong D, Lam CL, McGhee S, Lai WW. Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol 2009;93:1431-1436
11. Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology 2006;113:1450-1454
12. Bartley GB, Gorman CA. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 1995;119:792-795
13. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008;158:273-285
14. Sidoti PA, Dunphy TR, Baerveldt G, LaBree L, Minckler DS, Lee PP, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995;102:1107-1118
15. Estcourt S, Vaidya B, Quinn A, Shepherd M. The impact of thyroid eye disease upon patients' wellbeing: A qualitative analysis. Clin Endocrinol (Oxf) 2008;68:635-639
16. Charmaz K. The body, identity, and self. Sociol Q 1995;36: 657-680
17. Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114: 545-554
18. Papageorgiou E, Hardiess G, Schaeffel F, Wiethoelter H, Karnath HO, Mallot H, et al. Assessment of vision-related quality of life in patients with homonymous visual field defects. Graefes Arch Clin Exp Ophthalmol 2007;245: 1749-1758
19. Yeatts RP. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc 2005;103: 368-411